Chloe Spicer

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Group is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK.

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceutical Development Ltd. is a British company that engages in research and development of pharmaceutical products. The company is based in London, UK. Founded in 1990.

Shire Pharmaceutical Contracts Ltd. develops medicines for patients with rare diseases. The company was incorporated on June 2, 1986 and is headquartered in London, the United Kingdom.

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov.

Founded in 2003, Shire Holdings UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding company. The company is based in London, UK.

Founded in 1996, Shire Holdings Europe Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding British company. The company is based in London, UK.

Part of Takeda Pharmaceutical Co., Ltd., Shire Europe Ltd. is a holding British company that oversees the manufacturing and wholesale distribution of pharmaceutical medicines. The company is based in London, UK.

Founded in 2002, Shire Pharmaceuticals Services Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that manufactures and distributes pharmaceutical products. The company is based in London, UK.

Founded in 2001, Shire Investments & Finance (U.K.) Co. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that functions as an investment holding British company. The company is based in London, UK.

Part of Takeda Pharmaceutical Co., Ltd., Auralis Ltd. is a British company that develops and manufactures pharmaceutical products. The company is based in London, UK. The company was founded in 2005 by Simon Peter Bryson. Auralis was acquired by Shire ViroPharma, Inc., part of Takeda Pharmaceutical Co., Ltd. from January 27, 2014 on May 28, 2010 for $28.95 million.

Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom.

Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.